W Lester (Birmingham, UK) explains how anti-platelet agents work and gives evidence-based advice on peri-operative management.
W Lester (Birmingham, UK) explains how anti-platelet agents work and gives evidence-based advice on peri-operative management.
A Hofmann (Perth, Australia) discusses the economics of blood transfusion.
P Bolton – Maggs (Manchester, UK), its Medical Director, reviews the history and role of Serious Hazards of Transfusion (SHOT).
H New (London, UK) presents highlights from a multicentre survey of blood component use in paediatric cardiac surgery.
S Chisholm (Manchester, UK) describes the work of the NHS Technology Adoption Centre.
Mattia Glauber of Instituto Clinico Sant’ Amgrogio, Milan argues in favour of the right anterior mini-thoracotomy approach for the performance of minimally invasive aortic valve replacement. He uses a short video to illustrate the technique of sutureless valve insertion.
John Pepper of the Royal Brompton and Harefield Hospitals, London, United Kingdom, as part of a debate, puts forward the alternate view that there is not yet the evidence for superiority of minimally invasive aortic valve replacement over a full…
Christopher Young of St Thomas’ Hospital, London, UK reviews the evidence for minimally-invasive AVR. He argues that the advantages of this approach over full sternotomy can be seen particularly in the outcomes of high risk patients.
Eric Lim of the Royal Brompton Hospital, London, UK describes the benefits of using an endochamelon camera in performing VATS lobectomy. He includes an operative video of a sleeve resection.
S. Westaby (Oxford, UK) gives an overview of the use of temporary mechanical support for post cardiotomy failure.
Joseph Zacharias of the Lancashire Cardiac Centre, Blackpool, UK gives an overview of the evidence for the use of ablation for atrial fibrillation in minimal access mitral valve surgery. He demonstrates his use of cryoablation and reviews his results.
R. Venkateswaran (Manchester, UK) discusses temporary mechanical circulatory support as a bridge to transplantation in cardiogenic shock, considering the pathophysiology and the strategies which help decision-making.
W. Klepetko (Vienna, Austria) explains in detail the options available for complex airway resections in a variety of conditions.
A Klein (Cambridge, UK) explains the role of an anaesthetist in the transcatheter aortic valve implantation team.
D Souza (Örebro, Sweden) argues that an open vein harvest technique including peri-adventitial fat is best to optimise long-term patency.
J Pepper (London, UK) considers the causes of vein graft occlusion before looking at possible ways to improve results.
J Eaton (Oxford, UK) looks at models of cost-effectiveness to consider the benefits of transcatheter aortic valve implantation.
G. Angelini (London, UK) describes surgical techniques to improve vein graft patency rates.
G Di Giammarco (Chieti, Italy) describes his experience in graft flow measurement to improve patency outcomes.
M Ruel (Ottawa, Canada) discusses whether single internal mammary artery grafts can adequately supply the heart.
D Taggart (Oxford, UK) argues that CABG remains the best therapy for coronary artery disease in 2015.
F Melfi (Pisa, Italy) gives an overview of the evidence for the benefits of robotic surgery in the management of mediastinal disease.
G Rocco (Naples, Italy) considers the difficulties of defining the high risk patient for lung resection. He explains why he thinks that wedge resection remains a valid option is some cases and looks at the increasing importance of minimally-invasive approaches.
A Toker (Istanbul, Turkey) explains his views on the use of VATS and robotics for lung resection.
G Rocco (Turin, Italy) describes materials and techniques for chest wall reconstruction after resection.
D Taggart (Oxford, UK) reviews the evidence for using the radial artery as the first choice of second conduit in coronary bypass surgery.
P Kolh (Liege, Belgium) considers whether the SYNTAX trial has changed coronary artery disease practice in Europe. He reviews the results, examines the guidelines and emphasises the importance of risk models.
A Nakas (Leicester, UK) gives an overview of the surgical options before concluding that extended pleurectomy decortication should be used in suitable cases.
M Snee (Leeds, UK) explains how Stereotactic Ablative Radiotherapy (SABR) works and considers which patients are suitable for this treatment.
W Klepetko (Vienna, Austria) gives an overview of aspects of lung transplantation. He looks in detail at surgical techniques, donor organ utilisation, expanding the indications for surgery and the organisation of a service.
F Wells (Cambridge, UK) argues against the routine use of a minimal-access approach to mitral valve surgery. He recognises that good results for non-complex disease can be achieved in expert hands but believes that the open appoach is more appropriate…
P-E Falcoz (Strasburg, France) gives a detailed overview of the use of extracorporeal membrane oxygenation (ECMO) in thoracic surgery. He describes the different cannulation options and looks at future possibilities.
E Akowuah (Middlesbrough, UK) describes his early experience with the technique of aortic valve replacement via a manubrial incision.
M Bhabra (Wolverhampton, UK) describes the subclavian / axillary approach for transcatheter aortic valve implantation, with a video demonstration and case presentations.
S Nair (Cambridge, UK) gives an overview of a single centre ongoing trial of mini- versus full sternotomy for aortic valve replacement.
Aiman Alassar (London, UK) looks at the incidence of neurological injury with transcatheter aortic valve implantation, causative mechanisms and the use of protection devices.
J Sabik (Cleveland, USA), as part of a debate, argues that off-pump CABG should be abandoned as our default procedure. He reviews results from the major trials as well as metaanalyses to support his view.
M Borger (Leipzig, Germany) talks about his unit’s experience in dealing with complications of transcatheter aortic valve implantation.
W Lester (Birmingham) considers the use of non-red blood cell components in major haemorrhage, with emphasis on the role of fibrinogen.
C Young (London, UK) gives a detailed description of his techniques for minimal-access aortic valve replacement.
M Borger (Leipzig, Germany) reviews the current status of percutaneous tricuspid valve implantation.
N Davidson (Manchester, UK) covers minimally invasive procedures in the treatment of atrial arrhythmias, emphasising the benefits of an integrated approach.
B Gersak (Ljubljana, Slovenia) describes his techniques for performing aortic valve replacement via a right anterior mini-thoracotomy.
A McNab (Manchester, UK) describes the role of echocardiography in pre-procedural assessment, peri-procedural support and post-procedural follow-up of transcatheter aortic valve implantation cases. The mitraclip system is also considered.
B Gersak (Ljubljana, Slovenia) describes his techniques for minimally-invasive mitral valve surgery using an endoclamp.
P Dartevelle (Paris, France) gives a detailed description of tracheal replacement using a forearm free flap.
J Sabik (Cleveland, USA) considers the evidence for bilateral internal mammary artery usage in coronary bypass surgery. He uses data from the large Cleveland clinic registry to explore the importance of time, coronary vessel anastomosed, conduit used and patient factors…
R Gill (Southampton, UK) considers haemostatic mechanisms and the use of rFVIIa as a bail out adjunct.
C Young (London, UK) ponders the future of cardiac surgical training in the era of TAVI.
A de Souza (London, UK) describes his technique for endoscopic internal mammary artery harvest.
M Patrick (Manchester, UK) reviews the echocardiographic assessment of diastolic function.
F Melfi (Pisa, Italy) describes her experience in the use of robotics in thoracic surgery. She looks at the history of robotic developments before explaining the potential advantages. She gives a detailed review of the literature in this area and…
N Currie (London, UK) discusses the emerging roles of fibrinogen concentrate and prothrombin complex concentrate (PCC).
C Young (London, UK) and S Livesey (Southampton, UK) argue for the use of sutureless valves in high-risk aortic valve replacement.
M Buch (Manchester, UK) looks at the trans-femoral approach to trans-catheter aortic valve implantation, with emphasis on assessment, access and possible complications.
N Fletcher (London, UK) shows several examples of atrial myxoma and intra-cardiac thrombus.
A Macnab (Manchester, UK) gives a detailed description of the desirable TOE views in the assessment of the mitral valve.
S Ray (Manchester, UK) gives an overview of TOE use in assessing mitral regurgitation with normal leaflet motion.
S Reeves (Charleston, USA) reviews the SCA/ASE 2014 Perioperative Transoesophageal Echocardiography Guidelines.
L Winslow (Manchester, UK) explains the mechanisms leading to right heart problems in the adult congenital population.
A Denault (Montreal, Canada) describes in detail the current modalities available for cerebral monitoring.
J Ender (Leipzig, Germany) discusses the use of transoesophageal echocardiography in the setting of mechanical circulatory support.
K Görlinger (Essen, Germany) gives an overview on the management of postoperative coagulopathy based on ROTEM results.
J Thachil (Manchester, UK) gives some new insights into the coagulation cascade and the pathogenisis of bleeding after cardiac surgery.
M Bewsher (Manchester, UK) considers how TOE can help in the management of the postoperative unstable cardiac surgical patient.
V Bapat (London, UK) describes the Edwards transcatheter mitral valve replacement system, including a video animation and presentation of his early results.
A Vahanian (Paris, France) reviews the current status of percutaneous mitral valve repair and considers how this field may develop in the future.
A Macnab (Manchester ,UK) shows a variety of cases from the catheter laboratory illustrated with echo imaging.
T Richards (London, UK) details the importance of iron and its transport mechanisms. He then reviews the history of intravenous iron administration and looks at novel options.
P Perier (Bad Neustadt/Saale, Germany) reviews the evolution of minimally-invasive mitral valve surgery.
J Ender (Leipzig, Germany) considers functional restrictive mitral regurgitation, looking at mechanisms, measurements and therapeutic options.
A Klein (Cambridge, UK) reviews the incidence and causes of anaemia.
C von Heymann (Berlin, Germany) reviews the incidence of preoperative anaemia in cardiac surgery and considers its contribution to adverse outcomes.
G Sandhu (London, UK) explains the causes and describes his approach to managing airway stenoses in the adult.
C Royse (Melbourne, Australia) discusses the potential routine use of transthoracic echocardiography, as well as other ultrasound techniques, in preoperative assessment in the outpatient setting. <iframe width=”560″ height=”315″ src=”https://www.youtube-nocookie.com/embed/Wxiu7MbhS9M?rel=0&showinfo=0″ frameborder=”0″ allowfullscreen></iframe>
R Gill (Southampton, UK) discusses the role of fibrinogen in coagulation and the REPLACE trial of its use in complex cardiovascular surgery.
H Grocott (Winnipeg, Canada) explains the physiology of cerebral blood flow, looking at options for measurement and interventions to improve flow.
K Khan (Middlesbrough, UK) discusses his approach to anaesthesia in minimally-invasive mitral valve surgery, describing tips and tricks based on his unit’s experience.
M Buch (Manchester, UK) looks at the current indications and outcomes for the Mitraclip, including consideration of the Everest II trial and the 2012 European Valve Guidelines.
S Popat (London, UK) reviews the evidence for the use of chemotherapy in malignant mesothelioma and explores developing therapeutic options.
M Bennett (Plymouth, UK) considers how gaseous micro-emboli occur, what there effects might be, and how they might be prevented.
T McLeod (Birmingham, UK) discusses anaesthetic aspects of difficult airway management.
A Brunelli (Leeds, UK) reviews the evidence for electronic digital drainage systems. He explains the mechanism and benefits of regulated suction.
D Mazer (Toronto, Canada) discusses the pharmacological prevention of coagulopathy, looking in detail at the evidence for and against the use of tranexamic acid and aprotinin.
D Mazer (Toronto, Canada) considers the management of postoperative bleeding, looking in particular at the emerging evidence for component therapy.
JF Sabik (Cleveland, USA) considers whether the SYNTAX trial has changed practice in the USA and, if not, why not? He reviews the trial design and results before looking at registry data to inform about current patterns of coronary artery…
O Wendler (London, UK) explores the indications for transcatheter aortic valve implantation and the role of the heart team in decision-making.
J Swanevelder (Leicester, UK) examines the assessment of intra-operative paravalvular leak.
M Ranucci (Milan, Italy) explores the literature evidence for adverse outcomes associated with preoperative anaemia in cardiac surgery.
R Petersen (Copenhagen, Denmark) describes some difficult situations in VATS lobectomy before addressing training and the learning curve.
M Ranucci (Milan, Italy) discusses the bleeding patient and point of care testing, particularly with the use of TEG / ROTEM.
M Castella (Barcelona, Spain) uses a number of video clips to help explain his approach to minimally invasive atrial fibrillation surgery.
R Stanbridge (London, UK) describes the evolution of minimally invasive coronary surgery from his initial experience in 1995, and considers the results of the procedure.
M Borger (Leipzig, Germany) shows the 5 year Leipzig data for trans-apical transcatheter aortic valve implantation.
N Howell (Birmingham, UK) discusses aspects of data analysis and the building of a new risk model for aortic valve replacement.
T Sundt (Boston, USA) gives a brief overview of the evidence for various drugs which could be used to improve vein graft patency.
M Bewsher (Manchester, UK) describes the echocardiographic findings in acute aortic dissection.
R Firmin (Leicester, UK) presents an overview of paediatric extracorporeal membrane oxygenation. A Combes (Paris, France) gives a tutorial on VA and VV ECMO in adults.
A Kelleher (London, UK) considers the use of tranexamic acid to reduce bleeding in cardiac surgery.
D Jenkins (Cambridge, UK) discusses decision-making and management in acute severe right ventricular dysfunction after cardiopulmonary bypass.
I Birdi (Basildon, UK) discusses and shows a video demonstration of his techniques in minimally invasive mitral surgery.
C Palin (Oxford, UK), a cardiac anaesthetist, explains his view on how practice has become so polarised. This is followed by a panel and audience debate.
G Angelini (Bristol, UK) explains the evolution and current status of hybrid coronary revascularisation.
H New (London, UK) reviews coagulation, tests for coagulopathy, and changes in DIC and acute traumatic coagulopathy. Management strategies are discussed.
A Combes (Paris, France) describes mechanisms of right ventricular dysfunction and risk scoring for prediction, particularly in the contact of transplantation an LVAD therapy. Treatment options, including ECMO and RVAD implantation, are discussed. J Pepke-Zaba (Cambridge, UK) then discusses the…
J Zacharias (Blackpool, UK) describes some tips in performing endoscopic tricuspid valve surgery.
M Munavvar (Preston, UK) describes the use of semi-rigid thoracoscopy under sedation for the diagnosis and management of pleural diseases.
M Lemma (Milan, Italy) puts forward the argument in favour of off-pump coronary bypass surgery.
N Curzen (Southampton, UK) explains the importance of physiological ischaemia and FFR in deciding optimal management for coronary disease.
C Royse (Melbourne, Australia) explains why he believes that the key to reducing risk of stroke is aortic assessment.
A Brunelli (Leeds, UK) explains the use of digital drains in thoracic surgery and looks at the evidence for their benefits.
P Van Schil (Antwerp, Belgium) stresses the importance of correct terminology before reviewing the results of landmark trials of surgery in the management of mesothelioma.
F Guarracino (Pisa, Italy) explains how ultrasound can be used in the diagnosis of intra-thoracic diseases.
E Orion (Tel Aviv, Israel), the co-inventor of the device, looks at the evidence for using an external support to improve vein graft patency.
G. Angelini (London, UK) considers the evidence for single versus multiple arterial grafts in coronary bypass surgery, looking to explain why saphenous vein remains the second conduit of choice in the majority of cases worldwide.
J Brennan (Liverpool, UK) discusses the use of endovascular stenting in the treatment of acute aortic syndromes.
A Toker (Istanbul, Turkey) gives an overview of pulmonary infections which may require surgical intervention.
G Massard (Strasbourg, France) discusses the causes of a residual pleural space and considers the options for management.
D Taggart (Oxford, UK) looks at the evidence for external stenting of vein grafts to optimise long-term outcomes.
A. Newby (Bristol, UK) discusses the incidence and causes of vein graft failure. He considers options to improve outcomes, in particular the use of periadventitial human stem cells.
A Toker (Istanbul, Turkey) gives an overview of the surgical options for treating intra-pleural sepsis, emphasising the potential uses of VAC therapy.
D Cheng (London, Canada) gives an overview of the anaesthetic implications of minimally invasive mitral surgery.
J Elefteriades (New Haven, USA) gives ten clearly illustrated technical tips for use in aortic surgery.
R Hasan (Manchester, UK) gives an overview of the alternative conduits for bypass grafting. A de Souza (London, UK) reviews to evidence for these conduits.
V Bapat (London, UK) introduces the trans-aortic approach to trans-catheter aortic valve implantation, including a video demonstration.
A Klein (Cambridge, UK) looks at blood conservation measures in cardiac surgery.
F Wells (Cambridge, UK) discusses the difficult area of tricuspid regurgitation and failing right ventricular function late after mitral valve surgery.
M Buch (Manchester, UK) reviews the status of and indications for transcatheter mitral valve therapies.
D Taggart (Oxford, UK) argues in favour of using bilateral internal mammary arteries for surgical revascularisation.
A Borger (Leipzig, Germany) considers the role of a surgeon in transcatheter aortic valve implantation.
E Akowuah (Middlesbrough, UK) shares his experience of setting up a minimally-invasive coronary surgery programme.
H Skinner (Nottingham, UK) discusses aortic stenosis guidelines, estimation of severity, and patient-prosthesis mismatch.
G Murphy (Leicester, UK) dissects the evidence for an association between blood transfusion and adverse outcome.
M Solinas (Massa, Italy) presents his experience with the right anterior mini-thoracotomy approach for aortic valve replacement, including a video demonstration of the sutureless technique with the Perceval prosthesis.
P Van Schil (Antwerp, Belgium) presents videos with the use of robotics in the resection of mediastinal masses. D Breen (Galway, Ireland) shows some cases of airway obstruction management.
J Ender (Leipzig, Germany) shows cases of circumflex artery injury during mitral valve repair and explains the anatomy to demonstrate how easily this can happen.
D Taggart (Oxford, UK) undertakes a detailed exploration of the evidence for and against off-pump CABG.
S Thorne (Birmingham, UK) reviews the preoperative assessment of the right ventricle and the tricuspid valve, stressing the importance of protection of RV function in the long-term.
N Howell (Birmingham, UK) presents his unit’s experience with carcinoid heart disease. T Oelofse (Birmingham, UK) discusses the anaesthetic principles of managing these patients.
M Seeberger (Basel, Switzerland) gives a detailed description of right ventricular preoperative imaging, with emphasis on extra TOE views to improve assessment.
T Sundt (Boston, USA) gives a North American view of radial artery use as a bypass conduit.
D Sugarbaker (Boston, USA) illustrates in detail his techniques for extrapleural pneumonectomy and pleurectomy/decortication.
T Sundt (Boston, USA) discusses the timing of aortic intervention. G El Khoury (Brussels, Belgium) describes repair of a bicuspid regurgitant aortic valve, talking through a video of the David V technique. C Liopsis (London, UK) gives an update on…
G Murphy (Leicester UK) introduces blood management and how it affects outcomes in cardiac surgery.
B Bridgewater (Manchester, UK) presents provisional analysis of off-pump vs on-pump CABG from the SCTS database.
B Fabri (Liverpool, UK) explores the role of the radial artery as a conduit for bypass grafting.
A Wechsler (Philadelphia, USA) explores some of the reasons for polarisation of surgical opinion, including intuition and the retention of biases.
A Roscoe (Toronto, Canada) describes echocardiography techniques for viewing the tricuspid valve and predictors of repair failure.
M Dalrymple-Hay (Plymouth, UK) gives an update on the rapidly evolving field of new mitral valve technologies.
V Ramani (Manchester, UK) lectures on how the use of robotics in urology has improved outcomes.
D Glineur (Brussels, Belgium) discusses the off-pump CABG trials and argues for the use of bilateral internal mammary arteries as a composite Y-graft.
D Taggart (Oxford, UK) presents pre-syntax evidence for CABG vs PCI, before analyzing the results of the SYNTAX trial at four years.
P Perier (Bad Neustadt, Germany) discusses the mechanisms of functional tricuspid regurgitation. The importance of the right ventricle is stressed. Mechanisms of repair failure are described and indications for valve replacement given.
B Bridgewater (Manchester, UK) describes some of the statistical processes behind the SCTS database. A Wechsler (Philadelphia, USA) discusses different types of high level clinical trials and interpreting significance.
G Angelini (Bristol, UK) talks about surgical attitudes to evidence-based medicine, professional competition and lack of innovation.
N Howell (Birmingham, UK) explores whether RIMA-LAD revascularisation is equivalent to LIMA-LAD.
P Perier (Bad Neustadt, Germany) discusses the clinical significance of tricuspid valve regurgitation and options for surgical management.
D Cheng (London, Canada) reviews the rise and fall of aprotinin as an anti-fibrinolytic agent in cardiac surgery.
A Wechsler (Philadelphia, USA) reviews the surgical treatment for ischaemic heart failure (STITCH) trial. Problems with trial design, recruitment and results interpretation are highlighted.
P Punjabi (London, UK) describes the mechanisms involved in the development of tricuspid valve disease, imaging techniques for assessment and indications for intervention. Some operative videos of complex repairs are shown.
F Wells (Cambridge, UK) describes the similarities and fundamental differences between both the A-V valves and the ventricles. Important aspects of embryology, morphology and physiology are highlighted.
P Dartevelle (Paris, France) argues in favour of thoracotomy as the best approach for lung resections.
B Bridgewater (Manchester, UK) presents figures from the SCTS database comparing single versus bilateral mammary artery use in CABG.
The history of the Sorin company and its current innovative products are briefly described.
Product choice in valve replacement and a new ipad app are mentioned.
JP Herzog (Edwards), X Bertrand (Medtronic), U Lonn (St Jude) and K Leadley (JenaValve) give an overview of developments in the design of TAVI valves and delivery systems.